ABSTRACT
Introduction Therapeutic mammoplasty (TM) is a type of oncoplastic breast surgery (OBS) well suited to breast cancers in medium-large sized breasts with ptosis, and in some cases of large or multifocal/Multicentric (MF/MC) tumors. It includes contralateral symmetrisation. This report describes our experiences and outcomes of TM in breast cancer patients in a single institutional cohort in India.
Methods We present data for 207 cases (194 breast cancer, 13 benign disease) who underwent TM as part of their primary treatment. All patients underwent surgery after careful analysis of feasibility by a multidisciplanary tumor board and patient counselling. We report the clinicopathological profiles, surgical and oncological outcomes, and patient related outcome measures (PROMs) with different TM surgical procedures.
Results Patients were relatively young at a median age of 49 years with moderate-large breasts and grade II-III ptosis. Patients underwent simple (n=96), complex (n=79) or extreme TM (n=46). Low post-operative complication rates and good-excellent cosmetic scores were observed. With median follow-up of 26 months, 148 patients completed more than 1 year follow-up. The 1-year BREAST-Q PROMs revealed good-to-excellent scores for all types of therapeutic mammoplasty.
Conclusion We conclude that in a country where women present with large and locally advanced tumours, TM safely expands the indications for breast conservation surgery. PROMs scores show that this surgery is perceived to be physically and mentally satisfactory. With the popularization of this procedure, it is possible that more Indian patients with breast cancer will receive the benefits of breast conservation while maintaining their quality of life.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We acknowledge Bajaj Auto Ltd. for providing support to research activities at Prashanti Cancer Care Mission, Pune.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Independent Ethics Committee at Prashanti Cancer care Mission. The study was approved by an Independent Ethics Committee (DCDI/CDSCO registration number: ECR/298/Indt/MH/2018). All subjects gave their consent for the use of their personal and medical information including images in the publication of this study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The study investigators would like to state that all data related to the manuscript will be available for further review on request after consultation with institutional ethics committees
ABBREVATIONS (arranged alphabetically)
- BCS
- Breast Conservation Surgery
- BCT
- Breast Conservation Therapy
- DCIS
- Ductal Carcinoma In Situ
- EO
- Extreme Oncoplasty
- IDC
- Intraductal Carcinoma
- MF/MC
- Multifocal and/or Multicentric
- NAC
- Nipple Areolar Complex
- OBS
- Oncoplastic Breast Surgery
- PROMs
- Patient Reported Outcome Measures
- QoL
- Quality of Life
- RT
- Radiation Therapy
- SIB
- Simultaneous Integrated Boost
- TRM
- Therapeutic Reduction Mammoplasty
- UOQ
- Upper Outer Quadrant
